645 related articles for article (PubMed ID: 28889269)
1. Copper and Alzheimer's Disease.
Mathys ZK; White AR
Adv Neurobiol; 2017; 18():199-216. PubMed ID: 28889269
[TBL] [Abstract][Full Text] [Related]
2. The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide.
Drew SC; Barnham KJ
Acc Chem Res; 2011 Nov; 44(11):1146-55. PubMed ID: 21714485
[TBL] [Abstract][Full Text] [Related]
3. Metals and amyloid-beta in Alzheimer's disease.
Maynard CJ; Bush AI; Masters CL; Cappai R; Li QX
Int J Exp Pathol; 2005 Jun; 86(3):147-59. PubMed ID: 15910549
[TBL] [Abstract][Full Text] [Related]
4. Cu(II) interaction with amyloid-beta peptide: a review of neuroactive mechanisms in AD brains.
Lin CJ; Huang HC; Jiang ZF
Brain Res Bull; 2010 Jul; 82(5-6):235-42. PubMed ID: 20598459
[TBL] [Abstract][Full Text] [Related]
5. Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease.
Takahashi RH; Nagao T; Gouras GK
Pathol Int; 2017 Apr; 67(4):185-193. PubMed ID: 28261941
[TBL] [Abstract][Full Text] [Related]
6. Oligomeric amyloid-beta induces MAPK-mediated activation of brain cytosolic and calcium-independent phospholipase A
Palavicini JP; Wang C; Chen L; Hosang K; Wang J; Tomiyama T; Mori H; Han X
Acta Neuropathol Commun; 2017 Jul; 5(1):56. PubMed ID: 28750656
[TBL] [Abstract][Full Text] [Related]
7. Copper and clioquinol treatment in young APP transgenic and wild-type mice: effects on life expectancy, body weight, and metal-ion levels.
Schäfer S; Pajonk FG; Multhaup G; Bayer TA
J Mol Med (Berl); 2007 Apr; 85(4):405-13. PubMed ID: 17211610
[TBL] [Abstract][Full Text] [Related]
8. Early intraneuronal amyloid triggers neuron-derived inflammatory signaling in APP transgenic rats and human brain.
Welikovitch LA; Do Carmo S; Maglóczky Z; Malcolm JC; Lőke J; Klein WL; Freund T; Cuello AC
Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6844-6854. PubMed ID: 32144141
[TBL] [Abstract][Full Text] [Related]
9. Immunogold labeling and X-ray fluorescence microscopy reveal enrichment ratios of Cu and Zn, metabolism of APP and amyloid-β plaque formation in a mouse model of Alzheimer's disease.
Wang H; Wang M; Wang B; Li M; Chen H; Yu X; Yang K; Chai Z; Zhao Y; Feng W
Metallomics; 2012 Oct; 4(10):1113-8. PubMed ID: 22992540
[TBL] [Abstract][Full Text] [Related]
10. A vicious circle: role of oxidative stress, intraneuronal Abeta and Cu in Alzheimer's disease.
Bayer TA; Schäfer S; Breyhan H; Wirths O; Treiber C; Multhaup G
Clin Neuropathol; 2006; 25(4):163-71. PubMed ID: 16866297
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
12. Reactive oxygen species and Alzheimer's disease.
Multhaup G; Ruppert T; Schlicksupp A; Hesse L; Beher D; Masters CL; Beyreuther K
Biochem Pharmacol; 1997 Sep; 54(5):533-9. PubMed ID: 9337068
[TBL] [Abstract][Full Text] [Related]
13. Probing amyloid-β pathology in transgenic Alzheimer's disease (tgArcSwe) mice using MALDI imaging mass spectrometry.
Carlred L; Michno W; Kaya I; Sjövall P; Syvänen S; Hanrieder J
J Neurochem; 2016 Aug; 138(3):469-78. PubMed ID: 27115712
[TBL] [Abstract][Full Text] [Related]
14. The redox chemistry of the Alzheimer's disease amyloid beta peptide.
Smith DG; Cappai R; Barnham KJ
Biochim Biophys Acta; 2007 Aug; 1768(8):1976-90. PubMed ID: 17433250
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's disease and amyloid: culprit or coincidence?
Skaper SD
Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
[TBL] [Abstract][Full Text] [Related]
16. Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.
Cherny RA; Atwood CS; Xilinas ME; Gray DN; Jones WD; McLean CA; Barnham KJ; Volitakis I; Fraser FW; Kim Y; Huang X; Goldstein LE; Moir RD; Lim JT; Beyreuther K; Zheng H; Tanzi RE; Masters CL; Bush AI
Neuron; 2001 Jun; 30(3):665-76. PubMed ID: 11430801
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic treatment of Alzheimer's disease using metal complexing agents.
Price KA; Crouch PJ; White AR
Recent Pat CNS Drug Discov; 2007 Nov; 2(3):180-7. PubMed ID: 18221229
[TBL] [Abstract][Full Text] [Related]
18. [The role of copper in the pathophysiology of Alzheimer's disease].
Kessler H; Pajonk FG; Supprian T; Falkai P; Multhaup G; Bayer TA
Nervenarzt; 2005 May; 76(5):581-5. PubMed ID: 15905983
[TBL] [Abstract][Full Text] [Related]
19. Metals and Alzheimer's disease.
Adlard PA; Bush AI
J Alzheimers Dis; 2006 Nov; 10(2-3):145-63. PubMed ID: 17119284
[TBL] [Abstract][Full Text] [Related]
20. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
